Ibolya Dávid

Recent publications · Crossref

5 total works indexed

1. 2023 ESC Guidelines for the management of acute coronary syndromes

   · 2023 · cited 4,189x

2. Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial

   · 2019 · cited 2,789x

3. 2024 ESC Guidelines for the management of chronic coronary syndromes

   · 2024 · cited 2,318x

4. Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial

   · 2019 · cited 1,876x

5. Why is Tanimoto index an appropriate choice for fingerprint-based similarity calculations?

   · 2015 · cited 1,369x

via Crossref · CC0

Wikidata facts